zoledronic acid has been researched along with Pain, Intractable in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Q; Dong, M; Feng, FY; Feng, JF; Jiao, SC; Li, J; Liu, JW; Ren, J; Song, ST; Wang, XW; Wang, YJ; Wang, ZH; Xie, GR; Xu, N; Zhang, Y; Zhou, QH | 1 |
| Cai, W; Gao, YJ; Li, PW; Liu, B; Mao, GG; Wang, SJ; Zhang, G; Zhang, Y; Zhou, YF | 1 |
2 trial(s) available for zoledronic acid and Pain, Intractable
| Article | Year |
|---|---|
[Phase III clinical study of zoledronic acid in the treatment of pain induced by bone metastasis from solid tumor or multiple myeloma].
Topics: Adult; Aged; Analgesics; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Collagen Type I; Colorectal Neoplasms; Creatinine; Diphosphonates; Double-Blind Method; Female; Fever; Humans; Imidazoles; Lung Neoplasms; Male; Middle Aged; Multiple Myeloma; Pain Measurement; Pain, Intractable; Pamidronate; Peptides; Prospective Studies; Vomiting; Zoledronic Acid | 2008 |
[Phase II randomized clinical trail of zoledronic acid in treating metastatic bone pain of malignancy].
Topics: Adult; Aged; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Double-Blind Method; Female; Humans; Imidazoles; Male; Mannitol; Middle Aged; Pain, Intractable; Pamidronate; Prospective Studies; Zoledronic Acid | 2005 |